NCT01814241View on ClinicalTrials.gov

Mechanisms of Desensitization During Peanut Oral Immunotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Food Hypersensitivity
Interventions
DRUG

Open label peanut OIT

Subject will take increasing amounts of peanut protein up to a maximum maintenace dose of 1450mg.

Trial Locations (1)

27599

UNC Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT01814241 - Mechanisms of Desensitization During Peanut Oral Immunotherapy | Biotech Hunter | Biotech Hunter